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Contribution of teg49 Small RNA in the 5= Upstream Transcriptional
Region of sarA to Virulence in Staphylococcus aureus
Samin Kim,a Dindo Reyes,a Marie Beaume,b Patrice Francois,c Ambrose Cheunga
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USAa; Service of Infectious Diseases, Geneva
University Hospitals and Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerlandb; Genomic Research Lab, Services of Infectious
Diseases, Geneva University Hospital, Geneva, Switzerlandc

High-throughput RNA sequencing technology has found the 5= untranslated region of sarA to contain two putative small RNAs
(sRNAs), designated teg49 and teg48. Northern blot analysis disclosed that teg49 and teg48 were detectable within the P3-P1 and P1
sarA promoter regions, respectively. Focusing on teg49, we found that this sRNA, consisting of 196 nucleotides, is transcribed in the
same direction as the sarA P3 transcript. The expression of both P3 and teg49 transcripts is dependent on sigB and cshA, which encodes
a DEAD box RNA helicase. Within the sRNA teg49, there are two putative hairpin-loop structures, HP1 and HP2. Transversion mutation of the HP1 loop produced a smaller amount of sarA P3 and P2 transcripts and SarA protein than the corresponding HP1 stem and
the HP2 stem and loop mutations, leading to lower RNAII transcription and derepression of aur transcription. The HP1 loop mutant
also exhibited less biofilm formation than the parental and complemented strains. Complementation with shuttle plasmid pEPSA5
carrying teg49 was able to reestablish sarA P3 and P2 transcription and augment RNAII expression in the HP1 loop mutant. We thus
conclude that teg49, embedded within the extended promoter regions of sarA, is modulated by sigB and cshA and plays an important
trans-acting role in modulating the transcription and ensuing expression of sarA.

S

taphylococcus aureus, an opportunistic pathogen, is a major cause
of life-threatening infections in humans. The pathogenicity of S.
aureus is shaped by a variety of extracellular and cell wall-associated proteins that are expressed in a growth phase-dependent
fashion (1, 2). The expression of these virulence factors is controlled by a complex network of global regulatory elements, including agr and the staphylococcal accessory regulator (SarA) of S.
aureus. The sarA locus encodes a DNA binding protein, SarA, that
functions as a repressor or an activator by binding to conserved
AT-rich DNA motifs (ATTTTAT) in the promoter regions of target genes in agr-dependent and agr-independent manners (3, 4).
The sarA locus in S. aureus has an open reading frame (ORF) of
372 bp with a predicted molecular mass of 14,718 Da and a deduced pI of 8.52 (5). Notably, the 5= untranslated region (UTR) of
the sarA locus spans 860 bp with three promoters (6), encompassing three distinct but overlapping transcripts of 0.58 (P1), 0.84
(P3), and 1.15 (P2) kb, all encoding the SarA protein. The expression of these three transcripts is known to be growth phase dependent, with P1 and P2 expressed during the exponential phase and
P3 expressed postexponentially (6), and is thought to be required
for the complete restoration of SarA function (6). Because of the
unusual length of the sarA promoter region, it was hypothesized
that the 5= UTR may possess elements (e.g., small RNAs [sRNAs])
that are involved in optimal expression of the sarA gene.
S. aureus expresses a large number of sRNAs, many of which do
not possess well-described functions (7, 8, 9, 10, 11). Recent studies
have demonstrated that sRNAs of S. aureus are known to play a
pivotal role in a variety of regulatory processes by base pairing
with target mRNAs and by modulating protein activity (12, 13, 14,
15). For instance, sRNA RsaE pairs with the Shine-Dalgarno sequence of mRNAs of opp-3B/opp-3A (amino acid and peptide
transporter) and sucC (succinyl-coenzyme A synthase) and prevents the formation of a ribosomal initiation complex. It has been
suggested that RsaE may coordinate the downregulation of central
metabolism when carbon sources become limited (12). ArtR, a
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toxin-regulating sRNA, is involved in virulence regulation by activating alpha-toxin expression. ArtR also promotes degradation
of sarT mRNA by RNase III and arrests the translation of SarT by
direct binding to the 5= UTR of the sarT mRNA (13). SprD, a
sRNA expressed from S. aureus pathogenicity islands (PIs), represses translation initiation by base pairing with sbi mRNA, leading to impaired adaptive and innate host immune responses (14).
Morrison et al. (15) showed that SSR42, which is expressed predominantly during stationary phase, regulates the expression of
several virulence factors, including protein A, capsule, ␣-hemolysin, and Panton-Valentine leukocidin toxin. SSR42 is also involved in resistance to human polymorphonuclear leukocyte killing and pathogenesis in a murine model of S. aureus infection
(15).
Here we report the presence of an sRNA designated teg49 in the
sarA promoter region located within the P3-P1 promoter region.
Analyses by primer extension and 3= rapid amplification of cDNA
ends (RACE) revealed that teg49 is 196 nucleotides (nt) in length
and located at nt 667081 to 666886 of the reference S. aureus N315
genome. The teg49 transcript and the sarA P3 transcript were
diminished in cells lacking sigB or the DEAD box RNA helicase
gene cshA but restored in the complemented mutants. There are
two putative hairpin structures, designated HP1 and HP2, within
the teg49 sRNA. Replacement of the 7 nt in the HP1 loop of teg49
in the chromosome led to truncated transcripts from the P2
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TABLE 2 Primers used in primer extension and 3= RACE-PCR

TABLE 1 Strains used in this study
S. aureus
strain
RN4220
SH1000
Newman
ALC6094
ALC7201
ALC7252
ALC7286
ALC7288
ALC7289
ALC7290
ALC7291
ALC7869
ALC7870
ALC7909
ALC7911
a
b

Genotype and/or characteristic
Mutagenized strain 8325-4 that accepts
foreign DNA
Functional rsbU derivative of 8325-4 rsbU⫹
Isolated from a human infection in 1952
Strain Newman transduced with IPTGbinducible T7 polymerase; Tetr
ALC6094 ⌬cshA::Kanr
ALC7201 ⌬cshA::cshA
SH1000 sarA deletion
SH1000 HP1 stem mutation of teg49
SH1000 HP1 loop mutation of teg49
(ATTGCGC¡CGCTATA)a
SH1000 HP2 loop mutation of teg49
(GTCGATT¡TATCGGC)a
SH1000 HP2 stem mutation of teg49
Tn551::sigB in ALC6094
ALC7869 containing pSK236::sigB
ALC7289 containing empty vector pEPSA5
ALC7289 containing pEPSA5::teg49

Source or
reference
17
19
41
42
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Nucleotides replaced in chromosomal DNA.
IPTG, isopropyl-␤-D-thiogalactopyranoside.

and/or P3 promoters, resulting in reduced sarA expression, agr
expression, and biofilm formation, analogous to what has been
found in a sarA mutant.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture media. The bacterial strains used
in this study are listed in Table 1. S. aureus strain Newman and its derivatives ALC6094, SH1000, and RN4220 were grown at 37°C in tryptic soy
broth (TSB) or tryptic soy agar. Escherichia coli strains were grown in LB
broth or LB agar. The following antibiotics were used when appropriate:
erythromycin (5 g/ml), chloramphenicol (10 g/ml), tetracycline (2.5
g/ml), and kanamycin (50 g/ml) for S. aureus strains and ampicillin
(100 g/ml) and kanamycin (100 g/ml) for E. coli strains.
DNA manipulations and transformation. Standard procedures for
DNA manipulations were used for cloning (16). Restriction endonucleases and DNA-modifying enzymes were purchased from New England
BioLabs. E. coli and S. aureus plasmids were isolated with the QIAprep
Spin Miniprep kit (Qiagen). Transformations of E. coli and S. aureus cells
were carried out with a MicroPulser (Bio-Rad). Recombinant plasmids
obtained from E. coli were first transformed into S. aureus RN4220 for
proper DNA methylation to reduce restriction barriers (17). The plasmids
purified from RN4220 were then electroporated into S. aureus Newman
derivative ALC6094 (18) or SH1000 (19).
Construction of mutants and complementation in S. aureus. Allelic
exchange was carried out with the temperature-sensitive and Ermr pMAD
shuttle vector (20). The cshA mutant of strain ALC6094, a strain Newman
derivative that contains a T7 polymerase gene at the geh site (18), was
created with a kanamycin resistance cassette cloned into pMAD. Briefly,
PCR was used to amplify a 1.3-kb fragment comprising a 0.74-kb fragment upstream and a 0.56-kb fragment downstream of cshA with genomic
DNA as the template. The PCR fragment was cloned into pMAD, resulting in pMAD-⌬cshA. A SmaI-digested 0.9-kb fragment containing the
kanamycin resistance cassette was inserted into pMAD-⌬cshA to create
pMAD-⌬cshA::Kanr. The recombinant shuttle vector was transformed
into S. aureus ALC6094 (18). Transversion mutations of HP1 and HP2
loops and HP1 and HP2 stems in teg49 were introduced by PCR with
primers with altered nucleotides, cloned into pMAD, and transformed
into S. aureus SH1000. Allelic exchanges were performed as described

4370

iai.asm.org

Primer

Sequence

PS-1
PS-2
PS-3
PS-4
PA-11
PA-12
PA-13
PA-14

CATTTTTAGTGATAAAATTTTG
GGTAAATTATAAAAAATGCTG
GTTTTATAAACACTTTTTTG
GCAAAATTATGACTAACATATC
CTAAAGAGATTCTTTGTTATAGC
CAGCATTTTTTATAATTTACC
CAAAAAAGTGTTTATAAAAC
GATATGTTAGTCATAATTTTGC

previously (20). Selected mutants were subsequently complemented by
reintroducing pMAD-cshA and pMAD-teg49 into the chromosome by
homologous recombination as described previously (20). All of the mutant strains created were confirmed by PCR and sequencing.
Complementation of the HP1 loop mutant was also performed in
trans. In this instance, we cloned teg49 immediately downstream of the
xylose-inducible promoter in shuttle plasmid pEPSA5; this was followed by transformation into RN4220 and then into the HP1 loop
mutant. Pilot Northern analysis indicated that teg49 was expressed in
the HP1 loop mutant with recombinant plasmid pEPSA5::teg49 in the
presence of 1% xylose. The pEPSA5 vector in the HP1 loop mutant
served as the negative control.
RNA isolation, Northern blot analysis, and primer extension. Isolation of RNA and Northern blot hybridization were performed as previously described (18). Briefly, cells grown in TSB at 37°C were harvested at
optical densities at 650 nm (OD650s) of ⬃0.2, ⬃0.7, ⬃1.1, and ⬃1.7 with
18-mm borosilicate glass tubes in a Spectronic 20 (Spectronic Instrument), representing the early, mid-log, late log, and stationary phases,
respectively. Pellets were resuspended in 1 ml TRIzol (Invitrogen) with
0.1-mm glass/zirconia beads, and RNA was extracted as described previously (18). Total RNA (10 g) of each sample was electrophoresed
through a 1.5% agarose– 0.66 M formaldehyde gel in morpholinepropanesulfonic acid (MOPS) running buffer (20 mM MOPS, 10 mM sodium acetate, 2 mM EDTA, pH 7.0), transferred to a Hybond-N⫹ membrane (Amersham), hybridized with gel-purified PCR fragments
radiolabeled with [␣-32P]dCTP by the random-priming method (ReadyTo-Go Labeling kit; GE) under high-stringency conditions (21), washed,
and autoradiographed. Primer extension experiments were performed
with Moloney murine leukemia virus reverse transcriptase according to
the manufacturer’s instructions (Ambion) and 5= UTR-specific sarA oligonucleotide primers (Table 2).
Western blotting. Whole-cell extracts of S. aureus wild-type SH1000
or sarA mutants containing separate HP1 and HP2 stem and loop mutations grown to an OD650 of ⬃0.7 were prepared. The concentrations of
total proteins from clear lysates were determined with the Pierce BCA
Protein Assay kit (Thermo Scientific, IL) with bovine serum albumin as
the standard. Western blotting and detection were performed as described
previously (22).
Biofilm formation. Quantification of biofilm formation on abiotic
surfaces was done as described elsewhere (23). Briefly, S. aureus grown
overnight in TSB supplemented with 0.25% glucose (TSB-glucose) was
diluted 1:40 in TSB-glucose. This cell suspension was used to inoculate
sterile 96-well polystyrene microtiter plates (Iwaki Inc.) in triplicate. After
18 h of incubation at 37°C, wells were gently washed three times with 200
l of sterile phosphate-buffered saline, air dried in an inverted position,
and stained with 0.1% safranin for 30 s. Wells were rinsed again and
solubilized with ethanol, and the absorbance at 550 nm was determined
(FL800; BioTek Instruments). Each assay was repeated in five separate
experiments. Colony morphology was studied on Congo red agar as previously described (24).
RNA-Seq. teg48 and teg49 were previously discovered and reanalyzed
in the whole transcriptome of S. aureus N315 (10). Double-stranded
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FIG 1 RNA-Seq analysis of the sarA locus. (A) Architecture of the sarA locus. Three promoters located between ⫺710 and ⫺146 upstream of the sarA translation
start compose the topology of the sarA locus. (B) Schematic representation of the sarA region subjected to a transcriptomic study by RNA-Seq. An RNA-Seq
detection run shows different transcript signals upstream of sarA (top). The orientation run (middle) shows the similar transcription orientation of the two
smaller transcripts within the sarA locus and the transcription, in the opposite direction of sarA, of flanking gene SA0572, whereas the other flanking gene,
SA0574, is not expressed under the conditions studied. The annotated genome is depicted at the bottom.

cDNAs were synthesized with random primers from DNase-treated RNA.
cDNAs were fragmented by nebulization, ends were repaired, and fragments were ligated with Illumina genomic adapters. Size selection on
agarose gel allowed the selection of inserts of approximately 30 to 150 bp
that were used to construct the library by PCR amplification (see reference
10 for the detailed protocol). An sRNA orientation run was performed
with total RNA purified with the MirVana isolation and MicrobExpress
kits (Ambion) after 4 h of growth in rich medium. RNAs were prepared
with a dir-mRNA-SEQ protocol. After end repair, RNAs were ligated with
single-stranded sRNA adapters. After cDNA synthesis and PCR amplification for 15 cycles, the library was size selected on agarose gel to select
inserts of 15 to 100 bp. Sequencing was performed with an Illumina GAII
for 36 cycles. The reads obtained were mapped onto the annotated sequence of strain N315 (NC_002745) and analyzed with the Artemis genome viewer (25).
3= RACE assay. S. aureus strain N315 was grown for 4 h in MuellerHinton broth from a 0.1 McFarland suspension obtained from a diluted
overnight culture. Total RNA from a cell suspension treated with lysostaphin (50-g/ml final concentration) was purified with the RNeasy kit
(Qiagen). RNA quality and quantity were assessed with the Bioanalyzer
(Agilent) and NanoDrop ND-8000.
As the region upstream of sarA contains two RNA species, the transcripts were separated and purified on a 10% acrylamide gel. Two fractions with sizes of ⬍400 and ⬎400 nt were purified. RNA fractions were
polyadenylated with the MessageAmp Bacteria-Prokaryotic RNA amplification kit (Ambion). Poly(A) RNA fractions were immediately used for
nonspecific synthesis of cDNA with the SMARTer RACE cDNA amplification kit (Clontech). For 3= RACE-PCR, cDNA synthesis was performed

October 2014 Volume 82 Number 10

with 3=-CDS primer A (1 M final concentration) for 90 min at 42°C,
followed by 10 min at 70°C. cDNAs were diluted in 20 l Tricine-EDTA
buffer before proceeding to specific 3= RACE-PCR with Advantage 2 Polymerase Mix (Clontech) in accordance with the manufacturer’s instructions in 1⫻ Universal Primer Mix A and teg49 GSP2 primer at a 0.2 mM
final concentration. Samples were amplified by 30 cycles of 30 s at 94°C, 30
s at 62°C, and 3 min at 72°C. PCR products were purified by QIAquick
columns (Qiagen) and quantified. Finally, 3= RACE-PCR products were
sequenced with the BigDye Terminator Cycle Sequencing v.3.1 kit (Life
Technologies) with a 3130 XL device (Applied Biosystems). Sequences
were aligned with the N315 annotated genome sequence (RefSeq accession no. NC_002745) with Artemis software (25).

RESULTS

Identification of sRNA within the sarA locus by RNA-Seq.
Beaume et al. (10) have previously described the use of RNA-Seq
technology to obtain a representative map of the whole transcriptome of S. aureus strain N315. They identified 160 sRNA molecules in regions considered to be noncoding or intergenic. Some of
the sRNAs are localized in biologically or clinically relevant regions, between key metabolic or virulence genes or within PIs, in
strain N315 (10). Among these regions of interest, it was noticed
that the sarA region contains two putative sRNAs. These data were
reanalyzed, and we designated these sRNAs teg49 and teg48 (Fig.
1). The teg49 sRNA is located between the P3 and P1 promoters,
while teg48 resides between the P1 promoter and the sarA trans-
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FIG 2 Two sRNAs, teg49 and teg48, are detectable in the 5= UTR of the sarA gene. (A) Map of 5= UTR and sarA ORF. Two sRNAs, teg49 and teg48, are indicated
in the P3-P1 and P1 promoter regions, respectively. The transcription start sites of P2, P3, and P1 are marked at ⫺711, ⫺409, and ⫺149, with ⫹1 corresponding
to the sarA translational start site, as indicated by bent arrows. The P3 and P1 regions (black bars) were used as probes for Northern blot assays. The locations of
teg49 and teg48 in the 5= UTR of sarA are indicated at ⫺356 to ⫺164 and ⫺123 to ⫹4 (empty bars), respectively, with ⫹1 corresponding to the sarA translational
start site. (B, C) Northern blot assay detection of sRNAs teg49 (B) and teg48 (C). Total RNA (10 g) from S. aureus Newman derivative ALC6094 in various
growth phases (see Materials and Methods) were separated in a 1.5% agarose gel, transferred to an H⫹-bond membrane, and probed as described in Materials
and Methods.

lation start site (Fig. 2A), as confirmed by reanalysis by RNA-Seq
and Northern blot assay.
Northern blot analysis confirms the expression of two
sRNAs, teg49 and teg48, within the 5= UTR of sarA. To verify the
existence of both teg49 and teg48, we performed Northern blot
assays with radiolabeled P3 and P1 fragments (Fig. 2A). Total
cellular RNA of strain ALC6094, a derivative of strain Newman
(Table 1), was extracted at various time points after inoculation. A
probe from the sarA P3 region (⫺409 to ⫺147, where ⫹1 is the
sarA translational start site) hybridized with three distinct transcripts of 1.15, 0.8, and 0.2 kb. The 1.15- and 0.8-kb transcripts
correspond to the sarA P2 and P3 transcripts (6), while the
⬃0.2-kb transcript is a sRNA corresponding to teg49 (Fig. 2B).
Likewise, teg48 was also visualized with a P1 probe (⫺147 to ⫺1)
in Northern blot assays. More specifically, a labeled P1 probe
(⫺147 to ⫺1) yielded four bands, corresponding to sarA P2, P3,
and P1 transcripts and also teg48 at ⬃200 nt (Fig. 2C).
Mapping the 196-nt teg49 sRNA within the P3-P1 promoter
region. We initially focused on teg49 within the P3-P1 sarA promoter region. To map the start site and direction of transcription
of teg49, we designed DNA primers from sense and antisense
strands in the P3 promoter region (spanning ⫺406 to ⫺147 of the
translational start site of sarA) for primer extension (Table 2) (Fig.
3A). Primer extension analysis with primer PA-13, representing
the antisense strand, produced two clear transcripts, one larger
transcript for P3 and a smaller transcript corresponding to the
start site of teg49, while primers PS-1, -2, -3, and 4 of the sense
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strain (Table 2) did not yield any transcript (Fig. 3B). Primers
PA-11 and PA-12 of the antisense strand both produced single
transcripts, with one larger and one smaller than the corresponding sarA P3 transcriptional start site as identified by PA-13 (6).
These results indicate that the sRNA teg49 exists and is transcribed
in the same direction as the sarA P3 transcript.
To determine the exact size of teg49, we mapped the 5= end of
the sRNA by primer extension with a sequencing ladder and the 3=
end by RACE-PCR assay. Using primer PA-13, which produced
an additional band on the gel (arrow in Fig. 3C), we mapped the 5=
end of teg49 to nt 667081 of the S. aureus N315 genome by primer
extension (Fig. 3C). We also mapped the 3= end of teg49 to nt
666886 in the S. aureus N315 genome with the 3= RACE-PCR assay
(Fig. 3D). Thus, the teg49 sRNA, at 196 nt in length, is located
within the sarA P3-P1 promoter region.
Expression of both P3 and teg49 transcripts is cshA and sigB
dependent. In recent studies, it has been reported that CshA, a
DEAD box RNA helicase (26), can alter the stability of the agr
mRNA in S. aureus. To assess if CshA can regulate the expression
of sRNA teg49 and its associated sarA transcripts, we conducted
Northern blot assays of parental strain ALC6094 and its isogenic
cshA mutant and the complemented mutant with a teg49 probe.
As shown in Fig. 4A, neither a sarA P3 transcript nor teg49 was
readily detectable in the cshA mutant during the early, mid-log,
and late log phases, in contrast to parental strain ALC6094 and the
complemented mutant. In addition, the corresponding P2 transcript level was also lower in the cshA mutant than in the parental
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FIG 3 Primer extension studies of two transcripts in the sarA P3 promoter region. (A) Map of sarA and the 5= UTR. The directions of transcription of P2, P3,
and P1 are indicated by arrowheads. The oligomers used for primer extension are shown above and below the sarA genetic map. The directions of the oligomers
are indicated by arrowheads. The oligomers were customized from the sense strand (PS-1, PS-2, PS-3, and PS-4) and the antisense strand (PA-11, PA-12, PA-13,
and PA-14) (Table 2). (B) Primer extension analysis of teg49 containing putative primer extension products from the sense and nonsense strands, including a
control reaction mixture (lane ctl) that contained only total RNA prepared from S. aureus ALC6094. The transcriptional start sites of P3 (at ⫺409 from the
translational start site of sarA) and teg49 (at ⫺357 from the translational start site of sarA) are indicated by asterisks and a diamond, respectively. Lane M
contained molecular size markers. (C) Primer extension with oligomer PA-13 and total RNA isolated from S. aureus ALC6094 grown to exponential phase
(OD650 of 0.7) in TSB medium as the template. The transcriptional start sites of P3 and teg49 are indicated on the right. A part of the sequence of the P3 promoter
deduced from the sequencing reaction is shown on the left; P3 and teg49 starting sites from T’s (complementary nucleotides of A’s) are indicated by bold letters
and arrowheads. wt, wild type. (D) 3= RACE DNA sequencing reactions indicating the 3= end of teg49.

and complemented strains. Interestingly, both teg49 and sarA P3
transcripts, as detected by Northern blot assays, reemerged in cells
grown to the stationary phase (OD650 of 1.7) (Fig. 4A), suggesting
that factors other than CshA may be important in the generation
of sRNA teg49 and the sarA P3 transcript during the stationary
phase.
To confirm the Northern blot assay results for exponentialphase cells, we conducted primer extension studies of the cshA
mutant, isogenic parental, and complemented strains at an OD650
of 0.7 with primer PA-13. We found weaker primer extension
signals for both sarA P3 and teg49 in the cshA mutant than in the
parental and complemented strains (Fig. 4B). More specifically,
the cshA mutant exhibited notably lower levels of primer extension signals for teg49 (⬃2.4-fold lower, as determined by densitometry) (Fig. 4C) and the sarA P3 transcript (⬃4.7-fold less) (Fig.
4D) than the isogenic parent.
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In previous studies, we and others have shown that sigB regulates sarA P3 transcript expression in S. aureus (27, 28). As SigB is
involved in the postexponential stress response and teg49 somehow reemerges in a cshA mutant during the stationary phase, we
evaluated whether sigB is involved in the expression of sRNA
teg49. As expected, the sarA P3 transcript level was significantly
lower in the sigB mutant than in parental strain ALC6094 and also
the complemented mutant (Fig. 4E). Remarkably, sRNA teg49
was not observed in the sigB mutant, even during the stationary
phase (OD650 of 1.7, Fig. 4E), suggesting that teg49 expression is
dependent on sigB. Thus, the sigB mutant of ALC6094 cannot
generate either a sarA P3 transcript or sRNA teg49 but the two
transcripts reemerged in the complemented sigB mutant. In contrast to the cshA mutant, the sigB mutant did not yield any sarA P3
transcript or sRNA teg49 in any of the three growth phases, including the stationary phase (Fig. 4E).
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FIG 4 Northern blot analysis of sRNA teg49 in S. aureus strains in various phases of growth. (A, E) Northern blot assay detection of sRNA teg49. Total RNAs (10
g) from ⌬cshA (A) and ⌬sigB (E) mutants of strain Newman derivative ALC6094 grown in TSB medium were separated in a 1.5% agarose gel and then
transferred to an H⫹-bond membrane for probing. sRNA teg49 was detected with a teg49 probe. (B) Primer extension analysis of sRNA teg49 in a cshA mutant
of ALC6094. Primer extension assays were performed with RNAs purified from the parental (ALC6094), ⌬cshA mutant, and complemented strains grown to
exponential phase (OD650 of ⬃0.7) in TSB medium with oligonucleotide PA-13 (Table 2). ctrl, control; wt, wild type. (C, D) Quantification of sarA P3 and teg49
transcripts in the cshA mutant, parental, and complemented strains from panel B. Transcripts sarA P3 (C) and sRNA teg49 (D) were quantified with ImageJ
(NIH). These experiments were repeated at least three times, and one set of typical experiments is shown.

sRNA teg49 has two hairpin structures and sequences conserved among S. aureus strains. The RNA structure of teg49 was
predicted by the RNAfold web server (http://rna.tbi.univie.ac.at
/cgi-bin/RNAfold.cgi) (Fig. 5A). The sRNA teg49 appears to have
two stem-loop structures, each with a long stem and a short loop,
designated HP1 and HP2. HP1 and HP2 are located at nt 667059
to 667067 and 667018 to 667027 of the S. aureus N315 genome
(Fig. 5A), respectively. The sequences of teg49 are also highly conserved among methicillin-resistant and -susceptible S. aureus
strains (Fig. 5B).
HP1 loop mutation of teg49 has a prominent effect on sarA
P3 expression. Previous experiments have shown that hairpins in
noncoding sRNAs are important sites for posttranscriptional gene
regulation (12, 13, 14). Given the conservation of teg49 among
various S. aureus strains, we thus wanted to elucidate the contribution of the loop and stem sequences of HP1 and HP2 on sarA
expression. In this instance, we elected to work with strain
SH1000, which is a version of strain 8325-4 with rsbU restored that
is more genetically amenable and has been extensively studied. To
ensure that teg49 is also present within the sarA promoter region
of strain SH1000, we conducted a Northern blot assay with a teg49
probe, which showed that teg49, along with P2 and P3 sarA transcripts, was easily detectable in this strain (Fig. 6A, first lane). We
subsequently created chromosomal transversion mutations of
teg49 in SH1000, yielding an HP1 stem mutant (ALC7288), an
HP1 loop mutant (ALC7289), an HP2 loop mutant (ALC7290),
and an HP2 stem mutant (ALC7291) (Table 1). The expression of
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teg49 with a teg49 probe appeared to be reduced in two loop
mutants, ALC7289 (HP1 loop mutant) and ALC7290 (HP2 loop
mutant), but not in two stem mutants (Fig. 6A). Surprisingly, in
the HP1 loop mutant, where there is a 7-base transversion mutation in the chromosome, the P3 and P2 transcripts are almost
undetectable or are significantly reduced (Fig. 6A). Thus, the HP1
loop in teg49 seems to be critical for sarA P3 and teg49 transcription.
To analyze the effect of the HP1 loop mutation of teg49 on sarA
P2 and P3 transcription more clearly, we ran a lower-percentage
agarose gel (0.7% in Fig. 6B versus 1.5% in Fig. 6A) for Northern
blot assays with a sarA probe (sarA coding region) (Fig. 6B). As
expected, compared to the parental and complemented strains,
the HP1 loop mutant exhibited lower levels of sarA P1, P3, and P2
transcript expression. Remarkably, there were two additional
bands, one located between the P2 and P3 transcripts (one asterisk
in Fig. 6B) and the other located between the P3 and P1 transcripts
(two asterisks in Fig. 6B) in the HP1 loop mutant. The origin of
these two transcripts is not clear. However, it is plausible that the
larger transcript is a truncated form or processed from the P2
transcript while the smaller transcript can be derived from either
the P2 or the P3 transcript, indicating that the 7-base HP1 loop
sequence is critical to processing of the sarA transcripts. More
importantly, processing of the sarA transcripts is associated with
reduced expression of teg49 (Fig. 6A). Notably, complementation
of the 7-base mutation in the HP1 loop mutant in the chromo-
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FIG 5 Predicted secondary structure and comparison of the teg49 nucleotide sequences of S. aureus strains. (A) Predicted secondary structure of sRNA teg49.
The structure of teg49 was predicted by the RNAfold web server (see Results). Two hairpin-loop structures, HP1 and HP2, within teg49 were found to be located
at nt 667059 and 667018 of the S. aureus N315 genome, respectively. (B) Sequences upstream of the sarA coding region bearing putative sRNA teg49 are
conserved. A partial alignment of the teg49 sequences of S. aureus strains, Newman, USA300, COL, NCTC 8325, Mu50, N315, MW2, and MRSA252 is shown.
The HP1 and HP2 hairpin-loop sequences are shaded in gray and boxed, respectively.

some restored the transcription of all three sarA transcripts in the
mutant (Fig. 6B).
The effect of HP1 loop mutation on sarA transcription also
includes lower SarA protein expression than in the parental and
complemented mutant strains in whole-cell lysates of Western
blot assays probed with an anti-SarA monoclonal antibody, but
the level of expression was still higher than that of the sarA deletion mutant (Fig. 6C). Given that sarA is a positive regulator of agr
expression (29), we conducted Northern blot assays with an agrA
probe, which showed that RNAII (containing agrA) expression
was lower in the HP1 loop mutant than in the parental and complemented mutant strains (Fig. 6B). However, the reduction was
less than that of a true sarA deletion mutant. We next examined
the aureolysin gene aur, which is negatively regulated by sarA (30).
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As expected, the expression of aur was upregulated in the HP1
loop mutant, similar to that in the sarA deletion mutant (Fig. 6B).
Previous studies have described a critical role for SarA in biofilm
formation by S. aureus (31, 32). As anticipated for a strain with
reduced SarA expression, the HP1 loop mutant also exhibited less
biofilm formation than the wild type and the complemented mutant (P ⱕ 0.01 versus the parent by the Student t test), but the
reduction in biofilm formation was less than that of the sarA deletion mutant (Fig. 6D).
Complementation of the HP1 loop mutant in trans with
pEPSA5 carrying teg49. To complement the HP1 loop mutation
in trans, we first cloned teg49 into pEPSA5, a shuttle plasmid containing a xylose-inducible promoter in E. coli; this was followed by
transformation into the HP1 loop mutant. We were able to detect
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FIG 6 Analysis of HP1 loop mutant with respect to sarA P3 and teg49 transcription. (A) Northern blot assay (from a 1.5% agarose gel optimized for sRNA detection)
of wild-type (WT) SH1000, HP1 stem and loop mutants (mut), and HP2 stem and loop mutants (from late-log-phase cells at an OD650 of 1.1) probed with a labeled teg49
probe. As expected, there are three transcripts from wild-type SH1000, sarA P2 and P3 transcripts, and teg49. The sarA P1 transcript was not expected to be detected by
the teg49 probe. (B) Northern blot assays (from a 0.7% agarose gel to detect transcript larger than 500 bases) of isogenic sarA strains along with an HP1 loop mutant and
a complemented (comp) HP1 loop mutant. The probes are the sarA coding region for sarA, agrA for RNAII, and aur for the aureolysin gene. 16S rRNAs were used as
loading controls. We included wild-type SH1000, a sarA deletion mutant, and complemented mutants for sarA transcripts (P1, P3, and P2 for 0.5, 0.8, and 1.1 kb,
respectively) as additional controls. The single and double asterisks represent altered sarA transcripts in the HP1 loop mutant. This defect was restored in the complemented HP1 loop mutant (HP1 LOOPcomp). (C) Western blot assay for SarA in isogenic sarA mutant strains with an HP1 loop mutant, a complemented mutant, and
HP2 stem and loop mutants. The blot was probed with an anti-SarA monoclonal antibody at 1:1,000, followed by conjugate. Rsr, a cellular protein that was constant
during growth, was used as a loading control and was detected by a mouse anti-Rsr antibody. (D) Biofilm formation by assorted sarA strains in microtiter wells containing
TSB and glucose. Cells were inoculated into wells and grown overnight. Biofilms were stained with crystal violet and solubilized with ethanol, and OD550s were read. sarA
mutant and complemented mutant strains were used as negative and positive controls, respectively.

teg49 expression in the HP1 loop mutant upon induction with 1%
xylose versus the empty-vector control (Fig. 7A). Using cells at an
OD650 of 1.1 in the presence of 1% xylose, we discovered by
Northern blot assays that the sarA P3 and P1 transcript levels were
significantly enhanced in the HP1 loop mutant upon xylose in-
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duction while cells without xylose induction or those with the
vector alone did not exhibit similar complementation. Interestingly, the cleaved transcript sizing between the P3 and P1 transcripts in the HP1 loop mutant persisted in the HP1 loop mutant
carrying pEPSA5::teg49, consistent with the combination of de-
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FIG 7 Northern blot analysis of S. aureus HP1 loop mutant containing pEPSA-teg49 in the presence of 1% xylose. An S. aureus HP1 loop mutant harboring
pEPSA5-teg49 or control empty pEPSA5 was grown in TSB containing 1% xylose at 37°C, and cells were harvested at late exponential phase (OD650 of 1.1) (A,
B) and at three different growth stages (OD650s of 0.7, 1.1, and 1.7) (C,D). Purified total RNAs (10 g/lane) were separated in a 1.5% agarose gel, transferred to
H⫹-bond membranes, and then hybridized with radiolabeled DNA probes for teg49 (A), sarA (B), agrA (C), and aur (D).

fective and normal HP1 loops of teg49 in this strain. Importantly,
the RNAII transcript, as detected by the agrA probe, was intensified in the HP1 loop mutant carrying pEPSA5::teg49 (Fig. 7C).
Likewise, the aureolysin gene aur was more repressed in the HP1
loop mutant with pEPSA5::teg49 than in cells with only the vector
control (Fig. 7D). Taken together, these data showed that teg49 is
likely a trans-acting sRNA that is capable of complementing the
defect in sarA transcription in the HP1 loop mutant.
DISCUSSION

The sarA locus encompasses the 372-bp sarA coding region preceded by a long ⬃800-bp 5= UTR that adopts a three-promoter
system responsible for modulating the abundance of the SarA protein. SarA is a pleiotropic regulator of virulence, oxidative stress,
and biofilm formation in S. aureus (1, 2, 23, 31, 32, 33). In this
study, we also detected two sRNAs in the 5= UTR of the sarA locus
and found that sRNA teg49 likely contributes to the virulence of S.
aureus by modulating SarA expression. This report thus adds to
the growing list of sRNAs involved in the control of bacterial virulence in S. aureus, including RNAIII, SprD, RsaE, SprA1, SSR42,
and ArtR (12, 13, 14, 15, 34, 35). Unlike the orientation of many of
the antisense sRNAs, teg49 is in the same direction as the sarA P1,
P3, and P2 transcripts, as determined by RNA-Seq and primer
extension studies (Fig. 1B). In the absence of any indication of a
riboswitch, teg49 is likely a trans-acting sRNA. We were able to
detect teg49 by Northern blot assays with a radiolabeled P3 (data
not shown) and/or teg49 DNA probe but not with the sarA P1 and
P2 and sarA ORF probes (data not shown), consistent with the
location of teg49 between the sarA P3 and P1 promoter regions, as
verified by mapping studies.
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The expression of sRNA teg49 appears to be sigB dependent.
However, we did not find a sigB-dependent promoter (GGGTAT at
the ⫺10 position) immediately upstream of the transcription start
site. Notably, the absence of teg49 from a sigB mutant coincides with
a lack of activation of the SigB-dependent sarA P3 promoter (27, 28)
in a sigB mutant, while sarA P3 transcript restoration was accompanied by the reemergence of teg49 in a complemented sigB mutant
(Fig. 4E). In addition, as expected with a sigB-dependent transcript
(i.e., sarA P3 transcript) (36, 37), teg49 was maximally expressed during the stationary phase (Fig. 4E). Finally, erratic processing of the P2
and P3 sarA transcripts in the HP1 loop mutant also reduced teg49
expression (Fig. 6A). Taking our findings together, we conclude that
teg49 does not have a promoter and is likely derived from the sigBdependent sarA P3 transcript.
We have shown that the expression of teg49 is cshA dependent.
CshA is an ATP-dependent DEAD box RNA helicase that unwinds
duplex RNA. CshA has been known to be involved in ribosome
biogenesis, ribosome assembly, and mRNA decay in a degradosome involving RNase J and Y and polynucleotide phosphorylase
(PNPase) (26). However, the protection (or stability) of sRNAs
such as teg49 by CshA has not been previously described. In addition, RNase E is absent from S. aureus. In a separate study, we
recently analyzed the transcriptome of a cshA mutant of ALC6094,
showing that CshA is indeed required for the preservation and/or
stability of at least 15 sRNAs in the S. aureus Newman RNome
(unpublished data). In contrast to the regulation of the sigB mutant, regulation of teg49 by cshA is active only from early to late log
phase since teg49 expression reemerged in the cshA mutant during
stationary phase (OD650 of 1.7) (Fig. 4A).
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In silico analysis indicated that teg49 forms two hairpin structures with small loops, which we called HP1 and HP2 (Fig. 5A).
These secondary structures are often the site of binding to other
mRNAs or proteins. To confirm the importance of these secondary structures, we performed transversion mutations of the stem
and loop sequences of HP1 and HP2. Mutational analysis of HP1
of teg49 indicated that the HP1 loop has a modulatory function
important for controlling virulence gene expression by regulating
SarA protein expression (Fig. 6C). In comparison to the parental
strain, the HP1 loop mutant with a 7-bp replacement (ATTGCG
C¡CGGTATA) in the chromosome not only exhibited tapered
expression of sarA P2, P3, and teg49 transcripts (Fig. 6A and B)
but also led to the formation of two truncated transcripts. The
larger truncated transcript is likely derived from the sarA P2 transcript, while the origin of the smaller truncated transcript is not
clear and may be the P2 or P3 transcript (Fig. 6B, asterisks). A
consequence of the modulation of sarA P2 and P3 transcripts as a
result of the HP1 loop mutation is reduced synthesis of the SarA
protein, resulting in the dysregulation of downstream genes, including increased aur but decreased RNAII expression (Fig. 6B).
Importantly, this has also led to reduced biofilm formation in vitro
in the HP1 loop mutant, but the level of reduction is less than that
of the sarA deletion mutant.
We have noticed that expression of teg49 was lower in the HP1
loop mutant than in the parent (Fig. 6A). To verify that teg49 can
act in trans to complement the HP1 loop mutant, we confirmed
that sarA P3 and P1 transcription can be restored close to the
parental level in this mutant by expressing teg49 from a xyloseinducible promoter in pEPSA5. Given that the orientation of
teg49 is identical to that of the sarA transcripts, we ruled out teg49
as a cis-acting sRNA. In the absence of a riboswitch structure and
the ability to complement in trans, we concluded that teg49 is
likely a trans-acting sRNA. On the basis of the studies reported
here, we propose that 5=-terminal stem-loop HP1 of teg49 is critical in contributing to the stability of sarA P3 and possibly other
sarA transcripts. This hypothesis also implies that the HP1 loop
sequence in teg49 may be important in preventing erratic processing by host RNases, presumably via an mRNA binding protein
that confers protection from defective processing. One plausible
candidate for this protection may be CshA, which is likely involved in the generation of teg49 (Fig. 4A) and possesses presumably RNA binding activity (38, 39, 40). Further investigations are
needed to verify this possibility.
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